Compare CCCC & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCCC | SRI |
|---|---|---|
| Founded | 2015 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.4M | 161.7M |
| IPO Year | 2020 | 1997 |
| Metric | CCCC | SRI |
|---|---|---|
| Price | $1.89 | $8.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $7.25 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.4M | 224.4K |
| Earning Date | 02-27-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,108,000.00 | ★ $874,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $3.54 |
| 52 Week High | $3.65 | $9.71 |
| Indicator | CCCC | SRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 72.07 |
| Support Level | $1.74 | $8.17 |
| Resistance Level | $1.90 | $9.71 |
| Average True Range (ATR) | 0.12 | 0.65 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 40.56 | 76.78 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.